PAION AG Key words Research UpdatePAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE COSMO PHARMACEUTICALS IN THE U.S.08Apr2019 1248 CETCESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation EU No...
↧